Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 23 January 2009, doi:10.1136/bmj.a3112
Cite this as: BMJ 2009;338:a3112
Ole M Ekeberg, research fellow 1, Erik Bautz-Holter, professor 1, Einar K Tveitå, research fellow 1, Niels G Juel, consultant physician 1, Synnøve Kvalheim, consultant physician 1, Jens I Brox, consultant physician2,3
1 Department of Physical Medicine and Rehabilitation, Ullevål University Hospital and Medical Faculty, University of Oslo, 0407 Oslo, Norway, 2 Department of Orthopaedics, Back Surgery and Physical Medicine and Rehabilitation Section, Rikshospitalet University Hospital and Medical Faculty, University of Oslo, 0027 Oslo, 3 Unifob Health, University of Bergen, Bergen, Norway
Correspondence to: O M Ekeberg o.m.ekeberg{at}medisin.uio.no
Design Double blind randomised clinical trial.
Setting Outpatient clinic of a physical medicine and rehabilitation department in Oslo, Norway.
Patients 106 patients with rotator cuff disease lasting at least three months.
Interventions Ultrasound guided corticosteroid and lidocaine injection in the subacromial bursa and lidocaine injection in the gluteal region (local group); corticosteroid and lidocaine injection in the gluteal region and ultrasound guided lidocaine injection in the subacromial bursa (systemic group).
Main outcome measures Difference in improvement in the overall shoulder pain and disability index score after six weeks.
Results Six weeks after the intervention, the mean difference in improvement in overall shoulder pain and disability index score between the local group and the systemic group was –5.2 (95% confidence interval –13.9 to 3.5); it was –4.1 (–12.3 to 4.1, P=0.32) after adjustment for baseline score. A small but statistically significant difference in improvement between groups occurred in favour of the local group for two secondary outcome measures: the Western Ontario rotator cuff index (8.1, 0.7 to 15.6) and change in main complaint (2.0, 0 to 4).
Conclusions No important differences in short term outcomes were found between local ultrasound guided corticosteroid injection and systemic corticosteroid injection in rotator cuff disease.
Trial registration Clinical trials NCT00640575 [ClinicalTrials.gov] .
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?
Read all Rapid Responses